Administration begins distributing 150M rapid tests for COVID-19 virus

Sep 29, 2020 - 02:35 PM
White House image

The Trump administration yesterday began distributing 150 million rapid point-of-care tests for the COVID-19 virus that it purchased in August, which will go to states and territories (100 million), nursing homes (18 million), assisted living facilities (15 million), home health and hospice care agencies (10 million), historically black colleges and universities, and tribal nation colleges.

Abbott Diagnostics plans to make up to 48 million of the BinaxNOW Ag Card antigen tests available monthly in the U.S. in the coming weeks.

The Food and Drug Administration last month authorized laboratories certified to perform moderate, high or waived complexity tests under the Clinical Laboratory Improvement Amendment to use the test to detect SARS-CoV-2 in nasal swabs from individuals whose health care provider suspects they have COVID-19 within seven days of symptom onset.

“Negative antigen tests do not need to be repeated or confirmed with a high-sensitivity molecular test when they are employed for routine screening or surveillance,” said Assistant Secretary for Health Admiral Brett Giroir, M.D.

 

Related News Articles

Headline
AHA responds to FDA request for information on AI-enabled medical devices
The AHA provided recommendations to the Food and Drug Administration Dec. 1 in response to a request for information on the measurement and evaluation of…
Headline
Permanent recall issued for Baxter ventilation system
The Food and Drug Administration has identified a Class I recall of Baxter Life2000 Ventilation Systems due to a cybersecurity issue discovered through…
Headline
CDC data shows rise in flu, COVID-19 cases across states 
Flu cases are growing or likely growing in 39 states, according to the latest Centers for Disease Control and Prevention data from Nov. 11. COVID-19…
Headline
Recall issued for mislabeled potassium chloride
The Food and Drug Administration yesterday published an announcement from Otsuka ICU Medical saying that the company issued a voluntary recall for a mislabeled…
Headline
Study finds flu, COVID-19 infection temporarily raises risk of heart attack, stroke 
A study published Oct. 30 by the American Heart Association found that people have an elevated risk of heart attack and stroke following flu and COVID-19…
Headline
CDC adopts ACIP recommendations for COVID-19, chickenpox vaccines
The Centers for Disease Control and Prevention will update its immunization schedules for the COVID-19 and chickenpox vaccines to adopt recent recommendations…